Effect of saturation of oxygen training in simulated altitude for Altitude Hypoxia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Altitude HypoxiaSimulated altitude - Other
Eligibility
18 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether different intensity and altitude exposure levels are more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise.

Eligible Conditions
  • Altitude Hypoxia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Baseline, 2-week, 4-week, 6-week, and 8-week

Baseline and 6- and 8-week
Change in cycling performance at altitude
Change in peak VO2
Baseline, 2-week, 4-week, 6-week, and 8-week
Change in erythropoietin
Change in hematocrit
Change in hemoglobin

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Effect of optimized training in simulated altitude
1 of 4
Effect of saturation of oxygen training in simulated altitude
1 of 4
Effect of heart rate training in simulated altitude
1 of 4
Effect of placebo training in non-simulated altitude
1 of 4

Active Control

Experimental Treatment

Non-Treatment Group

96 Total Participants · 4 Treatment Groups

Primary Treatment: Effect of saturation of oxygen training in simulated altitude · Has Placebo Group · N/A

Effect of saturation of oxygen training in simulated altitude
Other
Experimental Group · 1 Intervention: Simulated altitude · Intervention Types: Other
Effect of heart rate training in simulated altitude
Other
Experimental Group · 1 Intervention: Simulated altitude · Intervention Types: Other
Effect of placebo training in non-simulated altitude
Other
PlaceboComparator Group · 1 Intervention: Placebo simulated altitude · Intervention Types: Other
Effect of optimized training in simulated altitude
Other
ActiveComparator Group · 1 Intervention: Simulated altitude · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 2-week, 4-week, 6-week, and 8-week

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,922 Previous Clinical Trials
3,517,057 Total Patients Enrolled
Courtney M WheatleyPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18 - 70 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: